2,087,626 Axon Enterprise, Inc $AXON Shares Bought by Retirement Systems of Alabama

Posted by George Bondi on Nov 10th, 2026

Retirement Systems of Alabama raised its stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 12,328.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,104,560 shares of the biotechnology company’s stock after purchasing an additional 2,087,626 shares during the period. Axon Enterprise accounts for approximately 2.6% of Retirement Systems of Alabama’s investment portfolio, making the stock its 5th largest holding. Retirement Systems of Alabama’s holdings in Axon Enterprise were worth $889,219,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in AXON. State Street Corp lifted its position in shares of Axon Enterprise by 5,700.2% during the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after buying an additional 209,879,882 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of Axon Enterprise by 18,050.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock worth $7,400,094,000 after buying an additional 13,127,348 shares during the last quarter. Robeco Institutional Asset Management B.V. grew its position in shares of Axon Enterprise by 391,214.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock worth $2,952,943,000 after buying an additional 6,987,098 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in shares of Axon Enterprise by 5,022.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock worth $1,802,719,000 after acquiring an additional 4,183,302 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its stake in shares of Axon Enterprise by 8,432.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock worth $1,983,414,000 after acquiring an additional 3,496,493 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Trading Down 3.1%

NASDAQ AXON opened at $303.18 on Tuesday. Axon Enterprise, Inc has a 12-month low of $296.78 and a 12-month high of $665.07. The company has a fifty day simple moving average of $435.58 and a two-hundred day simple moving average of $473.66. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The stock has a market cap of $24.63 billion, a P/E ratio of 97.17, a P/E/G ratio of 8.06 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business’s revenue was up 27.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.17 EPS. On average, analysts forecast that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey Kunins sold 9,605 shares of Axon Enterprise stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares of the company’s stock, valued at $61,266,818.70. The trade was a 8.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the sale, the chief executive officer owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 37,397 shares of company stock worth $21,234,034. 4.20% of the stock is owned by company insiders.

Analyst Ratings Changes

AXON has been the subject of a number of analyst reports. Needham & Company LLC decreased their target price on shares of Axon Enterprise from $750.00 to $500.00 and set a “buy” rating for the company in a research report on Friday. Raymond James Financial set a $675.00 price target on Axon Enterprise in a research report on Thursday, October 15th. JPMorgan Chase & Co. decreased their price objective on Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating for the company in a report on Friday. Northland Securities set a $540.00 price objective on Axon Enterprise in a research report on Friday. Finally, The Goldman Sachs Group dropped their target price on Axon Enterprise from $715.00 to $675.00 and set a “buy” rating on the stock in a research note on Monday, September 21st. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $612.18.

Get Our Latest Research Report on AXON

Axon Enterprise Profile

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals.

The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Founded in 1993 as TASER International, the company adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into connected devices and software.